Financials
- Market Capitalization 3.84 B
- Employee 507
- Founded 2013
- CEO N/A
- Website www.denalitherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG008P7F869
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-5.56
Fiyat/satışlar oranı
—
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 1518 | AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 35.49 USD | -4.55% | -8.37% | +82.00% | +275.56% | 3.95 B USD | ||
| 1521 | IDYA IDEAYA Biosciences, Inc. - Common Stock | 40.40 USD | -3.28% | +1.84% | +11.88% | +24.00% | 3.90 B USD | ||
| 1537 | VKTX Viking Therapeutics, Inc. - Common Stock | 32.62 USD | -3.66% | -3.89% | -3.63% | +17.93% | 3.81 B USD | ||
| 1551 | TLX Telix Pharmaceuticals Limited - American Depositary Shares | 11.26 USD | -1.05% | -0.44% | +9.53% | +78.45% | 3.81 B USD |